FibroBiologics Inc (FBLG) Actualités

FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

HOUSTON, Sept. 06, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a...

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology

HOUSTON, Aug. 20, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a...

Form EFFECT - Notice of Effectiveness

Form POS AM - Post-Effective amendments for registration statement

Form 3/A - Initial statement of beneficial ownership of securities: [Amend]

Form 3/A - Initial statement of beneficial ownership of securities: [Amend]

Form 3/A - Initial statement of beneficial ownership of securities: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form 3/A - Initial statement of beneficial ownership of securities: [Amend]

FibroBiologics Files 2024 Second Quarter Report

HOUSTON, Aug. 07, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]